HCV Research UK is a consortium of clinical and scientific researchers from across the UK, which has recruited approximately 12,000 individuals who were infected with hepatitis C virus (HCV). Individu
These data are the raw and processed data associated with our paper, “ATG7 is a haploinsufficient repressor of tumor progression and promoter of metastasis”, published in PNAS in 2022.
